Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

UK ups drive for TSE (transmissible spongiform encephalopathy) diagnostic

This article was originally published in Clinica

Executive Summary

The international race to improve the diagnosis, treatment and transmission risk assessment of transmissible spongiform encephalopathies has received a major boost from a UK research funding group. £7 million ($10 million) has been awarded to fund a programme of 22 UK and EU public and private sector collaborations in fields that range from subclinical diagnosis of the disease to ways of assessing the effectiveness of surgical device sterilisation.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT066018

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel